RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 June 2011 | By Michael Matthews 

The US Food and Drug Administration (FDA) has proposed amending existing regulations to prevent disqualified investigators from conducting any type of agency-regulated clinical investigations. Currently, a disqualified investigator may still run clinical investigations with other types of products besides the type for which he or she was disqualified. For example, if an investigator is disqualified from running a trial on pharmaceuticals, they may still run trials on medical devices.

 

© 2022 Regulatory Affairs Professionals Society.